Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amwill Health CareBOM:544353 +1.95%43 Return-on-Tangible-Asset is 18.39% as of Mar. 2026, which is 35% below its 10-year median of 28.41. GuruFocus rates BOM:544353 with a GF Score™ of 43/100. The stock has 3 warning signs investors should review. Among 120 Medical Distribution companies, Amwill Health Care ranks better than 95.83% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Amwill Health Care's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹150.9 Mil. Amwill Health Care's average total tangible assets for the quarter that ended in Mar. 2026 was ₹821.0 Mil. Therefore, Amwill Health Care's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 18.39%.
The historical rank and industry rank for Amwill Health Care's Return-on-Tangible-Asset or its related term are showing as below:
BOM:544353'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -12.16 Med: 28.41 Max: 80.37
Current: 14.55
During the past 6 years, Amwill Health Care's highest Return-on-Tangible-Asset was 80.37%. The lowest was -12.16%. And the median was 28.41%.
BOM:544353's Return-on-Tangible-Asset is ranked better than 95.83% of 120
companies
in the Medical Distribution industry
Industry Median: 2.53
vs BOM:544353: 14.55
Amwill Health Care (BOM:544353) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Amwill Health Care Return-on-Tangible-Asset Related Terms
Amwill Health Care Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Amwill Health Care's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544353 vs MCK, COR, CAH: Return-on-Tangible-Asset Comparison
For the Medical Distribution subindustry, Amwill Health Care's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amwill Health Care Return-on-Tangible-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Amwill Health Care's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Amwill Health Care's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 18.39% mean?
Amwill Health Care (BOM:544353) has a Return-on-Tangible-Asset of 18.39% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Amwill Health Care and its competitors. This is 35% below median its historical median of 28.41. According to the industry distribution chart, Amwill Health Care ranks #5 out of 120 companies in the Medical Distribution industry, placing it in the top 4.2%.
Is Amwill Health Care's Return-on-Tangible-Asset too high?
Amwill Health Care's current Return-on-Tangible-Asset of 18.39% is 35% below median its 10-year median of 28.41. The Medical Distribution industry median Return-on-Tangible-Asset is 2.53. Amwill Health Care's value of 18.39% is 626.9% above this industry median. Based on the distribution chart, Amwill Health Care ranks #5 out of 120 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Amwill Health Care has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Amwill Health Care's Return-on-Tangible-Asset compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Amwill Health Care ranks #5 out of 120 companies for Return-on-Tangible-Asset. This places Amwill Health Care in the top 4% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.53. Amwill Health Care's value of 18.39% is 626.9% above this benchmark. While the company's 10-year median is 28.41 vs. the industry median of 2.53, Amwill Health Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Distribution company?
The median Return-on-Tangible-Asset among Medical Distribution companies is 2.53, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amwill Health Care's current Return-on-Tangible-Asset of 18.39% is 626.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Amwill Health Care and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Asset is 2.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amwill Health Care's current Return-on-Tangible-Asset is 18.39%, which is 35% below median its own 10-year median of 28.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amwill Health Care stock overvalued right now?
Amwill Health Care (BOM:544353) has a current Return-on-Tangible-Asset of 18.39%. The current Return-on-Tangible-Asset is 18.39%, which is 35% below median its 10-year median of 28.41 and 626.9% above the Medical Distribution industry median of 2.53. Amwill Health Care's overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Amwill Health Care (BOM:544353), the current Return-on-Tangible-Asset is 18.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Amwill Health Care Ltd is a derma-cosmetic development company. Its focus is on development of problem solving dermatological, cosmeceutical and aesthetical products. The product portfolio is divided into two categories, namely, development and contract manufacturing of generic dermatological solutions; and developing and formulating solutions to specific The company operates in only one segment which is dealing in pharma products.
43GF Score
Get the complete analysis for BOM:544353
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544353 has been successfully added to your 
